Dhanashree Verma faces criticism on 'Rise and Fall' from Manisha Rani. Rani calls Verma's Red Room statements baseless and influenced. This comes after cricketer Yuzvendra Chahal denied cheating ...
Rani Mukerji won her first National Award in 2025 after a 30-year career, for Best Actress in 'Mrs Chatterjee vs Norway'. Her mother praised her but felt she deserved the award earlier, especially for ...
Plans to relaunch the Van Rani train at Sanjay Gandhi National Park face delays due to theft and weather damage, prompting police intervention. MUMBAI: Plans to restart Van Rani (Queen of the Jungle), ...
British Prime Minister Sir Keir Starmer got a taste of Bollywood when he visited Mumbai's Yash Raj Studios. Rani Mukerji dutifully played the host even as her husband YRF Chairman Aditya Chopra ...
British PM Keir Starmer visited the YRF Studio in Mumbai on Wednesday, where he was hosted by Rani Mukerji and YRF CEO Akshay Widhani. The Yash Raj Films (YRF) studio hosts several bigwigs and ...
Actress Rani Mukerji met United Kingdom Prime Minister Keir Starmer on Wednesday, October 8, during his visit to Yash Raj Films (YRF) studio in Mumbai's Andheri suburb, a key hub of Bollywood ...
Kier Starmer visited Mumbai and was welcome by PM Modi. (Image: Reuters) PM Modi welcomed UK Prime Minister Kier Starmer in Mumbai earlier today. Starmer visited the Yash Raj Film Studio in Mumbai’s ...
UK Prime Minister Keir Starmer visited the Yash Raj Films (YRF) studio in Mumbai on Wednesday, a key hub for Bollywood production. He met Indian producers at the Andheri suburb studio. The United ...
United Kingdom Prime Minister Keir Starmer on Wednesday visited the Yash Raj Films (YRF) studio in Mumbai's Andheri suburb, a key Bollywood production hub. The visit aims at strengthening cultural ...
Gaye Sharpe is retiring as director of Polk County’s Parks and Natural Resources Division after 35 years of service. Sharpe was instrumental in the county's acquisition of over 26,000 acres of ...
(Reuters) -Rani Therapeutics on Friday announced a licensing deal to develop and sell an oral version of Chugai Pharmaceutical's experimental antibody, with options to expand to five additional drugs, ...